August 26, 2005 -- EVENDALE, Ohio - Shenzhen Airlines has signed a new 15-year OnPoint
SM
SM
SM
Rick Kennedy
GE Aviation
[email protected]
+1 513 243 3372
+1 513 607 0609
August 26, 2005 -- EVENDALE, Ohio - Shenzhen Airlines has signed a new 15-year OnPoint
SM
SM
SM
Rick Kennedy
GE Aviation
[email protected]
+1 513 243 3372
+1 513 607 0609
August 26, 2005 -- EVENDALE, Ohio - Shenzhen Airlines has become the newest customer for the CFM56-5B, placing an order for engines to power three Airbus A320 and two A319 aircraft. The engine order is valued at $60 million at list price.
CFM56-5B engines are produced by CFM International, a 50/50 joint company between Snecma and General Electric Company. CFM is the world's leading aircraft engine supplier, with more than 15,000 engines in service worldwide.
August 24, 2005 -- EVENDALE, Ohio - GE Transportation announced that an LM6000 aeroderivative gas turbine recently completed the 500-hour power generation phase of endurance testing towards American Bureau of Shipping (ABS) certification. GE is seeking ABS certification to the Steel Vessel and the new Naval Vessel Rules for its LM6000.
August 23, 2005 -- EVENDALE, Ohio - Singapore Airlines (SIA) signed a 10-year OnPoint
SM
SM
SM
Rick Kennedy
GE Aviation
[email protected]
+1 513 243 3372
+1 513 607 0609
August 22, 2005 -- Evendale, Ohio - The GE Rolls-Royce Fighter Engine Team (FET) has been awarded a contract valued at $2.4 billion to develop its F136 engine for the F-35 Joint Strike Fighter (JSF) program.
The contract, issued by the U.S. government, will be applied toward the System Development and Demonstration (SDD) phase of the F136 engine program. This SDD phase will run through September 2013. The F136 Initial Service Release is planned for 2012, at which time delivery of the first F136 production engines will begin.
MILWAUKEE--(BUSINESS WIRE)--Aug. 17, 2005--GE Healthcare, a unit of General Electric Company (NYSE:GE), announced today a new worldwide distribution/sales representation agreement with InSightec Image Guided Treatment Ltd. for the sales and marketing of ExAblate(R) 2000, the world's first magnetic resonance image (MRI) guided focused ultrasound system designed to non-invasively treat uterine fibroids.
CAMBRIDGE, Mass. & PISCATAWAY, N.J.--(BUSINESS WIRE)--Aug. 11, 2005--GE Healthcare, a unit of General Electric Company (NYSE:GE), today announced a collaboration with the Harvard Center for Neurodegeneration & Repair (HCNR) to use GE Healthcare's state-of-the-art cellular imaging system, the IN Cell Analyzer, to enhance research of the human central nervous system and neurodegenerative diseases like Parkinson's and Alzheimer's disease. In addition, HCNR and GE will work together to develop new software tools that will help speed disease analysis in the lab.